双抗治疗-话题@MedSci

#双抗治疗#

25篇内容 | 2022人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1429114, encodeId=b0ee1429114c9, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=Cardiovasc Ther：西班牙急性冠脉综合征(ACS)后双抗治疗时间？, objectType=article, longId=95894, objectId=048995894e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=048995894e0, replyNumber=0, likeNumber=99, createdTime=2017-04-16, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=048995894e0, moduleTitle=Cardiovasc Ther：西班牙急性冠脉综合征(ACS)后双抗治疗时间？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=048995894e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429113, encodeId=46991429113ee, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=Heart：预先双抗治疗或增加经导管主动脉瓣置入术患者出血风险, objectType=article, longId=94752, objectId=0c4d94e522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c4d94e522f, replyNumber=0, likeNumber=90, createdTime=2017-04-07, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c4d94e522f, moduleTitle=Heart：预先双抗治疗或增加经导管主动脉瓣置入术患者出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c4d94e522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429112, encodeId=89ef14291123b, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=这部分人接受1年双抗治疗获益更大！, objectType=article, longId=90131, objectId=4c1990131ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c1990131ea, replyNumber=0, likeNumber=73, createdTime=2017-03-01, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c1990131ea, moduleTitle=这部分人接受1年双抗治疗获益更大！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c1990131ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429111, encodeId=7fe7142911160, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布, objectType=article, longId=78092, objectId=6164e8092e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6164e8092e7, replyNumber=0, likeNumber=44, createdTime=2016-09-23, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6164e8092e7, moduleTitle=2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6164e8092e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429110, encodeId=29341429110ce, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=Eur Heart J：稳定性冠脉病患者长期双抗治疗不良事件增多, objectType=article, longId=47676, objectId=de254e6765e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de254e6765e, replyNumber=0, likeNumber=52, createdTime=2015-03-05, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de254e6765e, moduleTitle=Eur Heart J：稳定性冠脉病患者长期双抗治疗不良事件增多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de254e6765e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429109, encodeId=654d142910982, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究), objectType=article, longId=42882, objectId=28904288280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28904288280, replyNumber=0, likeNumber=84, createdTime=2014-11-21, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28904288280, moduleTitle=NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28904288280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429108, encodeId=958f142910888, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=AHA 2014：郭艺芳：冠脉药物支架术后双抗治疗需多久？, objectType=article, longId=42739, objectId=e6e342e396c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6e342e396c, replyNumber=0, likeNumber=85, createdTime=2014-11-20, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6e342e396c, moduleTitle=AHA 2014：郭艺芳：冠脉药物支架术后双抗治疗需多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6e342e396c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429107, encodeId=4c42142910e63, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=SCAI 2014 ：血管内介入后双抗治疗未改变主要不良事件, objectType=article, longId=36233, objectId=c4443623340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4443623340, replyNumber=0, likeNumber=70, createdTime=2014-06-12, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4443623340, moduleTitle=SCAI 2014 ：血管内介入后双抗治疗未改变主要不良事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4443623340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429106, encodeId=d306142910630, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=Am J Cardiol：延长置入DES患者双抗治疗增出血风险, objectType=article, longId=34858, objectId=1fb334858e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fb334858e2, replyNumber=0, likeNumber=60, createdTime=2014-05-18, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fb334858e2, moduleTitle=Am J Cardiol：延长置入DES患者双抗治疗增出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fb334858e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429105, encodeId=89b41429105e7, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=Lancet：PCI术后停止双抗治疗后心血管事件风险与停用原因有关, objectType=article, longId=27473, objectId=10852e47310, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10852e47310, replyNumber=0, likeNumber=48, createdTime=2013-12-05, rootId=0, userName=zhangbaojun, userId=4f6a4173831, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10852e47310, moduleTitle=Lancet：PCI术后停止双抗治疗后心血管事件风险与停用原因有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10852e47310)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429104, encodeId=6b1a142910496, content=<a href='/topic/show?id=168a3e464ad' target=_blank style='color:#2F92EE;'>#双抗治疗#</a>, objectTitle=Eur Heart J：ACS患者PCI后双抗治疗6个月以上心肌梗死风险显著降低, objectType=article, longId=26106, objectId=0a7826106be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a7826106be, replyNumber=0, likeNumber=52, createdTime=2013-11-03, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a7826106be, moduleTitle=Eur Heart J：ACS患者PCI后双抗治疗6个月以上心肌梗死风险显著降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a7826106be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

双抗治疗

2020-05-29

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

Cardiovasc Ther：西班牙急性冠脉综合征(ACS)后双抗治疗时间？

2017-04-16

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

Heart：预先双抗治疗或增加经导管主动脉瓣置入术患者出血风险

2017-04-07

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

这部分人接受1年双抗治疗获益更大！

2017-03-01

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布

2016-09-23

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

Eur Heart J：稳定性冠脉病患者长期双抗治疗不良事件增多

2015-03-05

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究)

2014-11-21

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

AHA 2014：郭艺芳：冠脉药物支架术后双抗治疗需多久？

2014-11-20

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

SCAI 2014 ：血管内介入后双抗治疗未改变主要不良事件

2014-06-12

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

Am J Cardiol：延长置入DES患者双抗治疗增出血风险

2014-05-18

zhangbaojun (审核中...)

前往app查看评论内容

#双抗治疗#

Lancet：PCI术后停止双抗治疗后心血管事件风险与停用原因有关

2013-12-05

智慧医人 (审核中...)

前往app查看评论内容

#双抗治疗#

Eur Heart J：ACS患者PCI后双抗治疗6个月以上心肌梗死风险显著降低

2013-11-03

科室
- - 订阅+
  - 更多科室
工具
服务